Impact of Anticoagulation Therapy on the Cognitive
Decline and Dementia in Patients with Non-Valvular Atrial Fibrillation
(Cognitive Decline and Dementia in Patients with Non-ValvularAtrial Fibrillation (CAF) Trial)
T. Jared Bunch, MD*†, Heidi May,
PhD*, Michael J. Cutler, DO, PhD*, Scott C. Woller, MD*‡, Victoria
Jacobs, NP, PhD*, Scott M. Stevens, MD*‡, John Carlquist, PhD*‡, Kirk U
Knowlton, MD*, Joseph B. Muhlestein MD*†, Benjamin A. Steinberg, MD,
MHS†, Jeffrey L. Anderson, MD*†
*Intermountain Heart Institute and Department of Medicine, Intermountain
Medical Center; Murray, Utah, USA
†Department of Internal Medicine, Division of Cardiology, University of
Utah School of Medicine, Salt Lake City, Utah, USA
‡Department of Internal Medicine, University of Utah School of Medicine,
Salt Lake City, Utah, USA
Address for correspondence: T. Jared Bunch, M.D.
University of Utah School of Medicine
Division of Cardiology, Department of Internal Medicine
50 N Medical Drive, Salt Lake City, Utah 84132
Phone: 801-585-7676
Fax: 801-581-7735
Email:
jared.bunch@hsc.utah.edu
Funding : This was an independent, investigator-initiated study
supported by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI).